Phase III radiation therapy oncology group (RTOG) trial 86-10 of androgen deprivation adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostate.
By M. Pilepich, K. Winter, M. John, J. Mesic, W. Sause, P. Rubin, C. Lawton, M. Machtay, D. Grignon. International Journal of Radiation Oncology, Biology, Physics, 2001
774 citations recorded by the source corpus.
Subfields: Pulmonary and Respiratory Medicine, Radiation
View Paper: https://www.semanticscholar.org/paper/b190fb408bb3425c87e8b3d5a51464619ff405ec
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Pulmonary and Respiratory Medicine
Citations in the corpus
- Guideline for the management of clinically localized prostate cancer: 2007 update. (2007, background): “Pilepich et al.(26) 1987 to 1991 Stage T2 to T4, M0, with or without pelvic lymph node involvement Radiation alone (n 230) or with goserelin 3.”
- Androgen suppression and radiation vs radiation alone for prostate cancer: a randomized trial. (2008, background): “Low riskf and endorectal MRI evidence of extracapsular extension or seminal vesicle invasion 2 (3) 1 (4) 1 (1) 1 (4)”